INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

89 hedge funds and large institutions have $382M invested in Inozyme Pharma in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 33 reducing their positions, and 9 closing their positions.

Holders
89
Holders Change
+9
Holders Change %
+11.25%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
22
Reduced
33
Closed
9
Calls
$45K
Puts
$246K
Net Calls
-$201K
Net Calls Change
-$1.54M

Top Buyers

1
AAA
1
Affinity Asset Advisors
New York
$20.2M
2
WP
2
Woodline Partners
California
$6.8M
3
EAM
3
Exome Asset Management
New York
$2.09M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$1.87M
5
KCM
5
Kennedy Capital Management
Missouri
$3.35M

Top Sellers

1
SC
1
Samlyn Capital
New York
$22.3M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.1M
3
OCA
3
Octagon Capital Advisors
New York
$0
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$40.8M
5
Millennium Management
5
Millennium Management
New York
$5.39M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$40.8M 5,328,856 -208,644 -4%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$34.4M 4,494,851 – –
SI
3
Sofinnova Investments
California
$32.8M 4,280,308 – –
RSCM
4
Rock Springs Capital Management
Maryland
$28.2M 3,681,174 – –
EAM
5
Eventide Asset Management
Massachusetts
$24.4M 3,179,837 – –
BlackRock
6
BlackRock
New York
$23.7M 3,088,653 +46,323 +2%
SC
7
Samlyn Capital
New York
$22.3M 2,912,913 -459,645 -14%
AAA
8
Affinity Asset Advisors
New York
$20.2M 2,642,519 +756,717 +40%
NMC
9
NEA Management Company
Maryland
$18.7M 2,437,689 – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$18.5M 2,419,020 +33,998 +1%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$15.1M 1,967,432 -304,874 -13%
SB
12
Samsara BioCapital
California
$12M 1,562,500 – –
SFM
13
Sphera Funds Management
Israel
$10.5M 1,372,907 -190,000 -12%
BOCH
14
Blue Owl Capital Holdings
New York
$9.73M 1,270,027 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$8.18M 1,067,479 +34,763 +3%
WP
16
Woodline Partners
California
$6.8M 888,067 +588,067 +196%
State Street
17
State Street
Massachusetts
$6.75M 880,639 +134,106 +18%
Millennium Management
18
Millennium Management
New York
$5.39M 703,606 -207,859 -23%
DMKJ
19
David M. Knott Jr
$4.32M 564,549 – –
KCM
20
Kennedy Capital Management
Missouri
$3.35M 437,657 +150,120 +52%
Northern Trust
21
Northern Trust
Illinois
$3.22M 419,879 -4,828 -1%
Goldman Sachs
22
Goldman Sachs
New York
$3.14M 409,923 +46,551 +13%
LCM
23
Laurion Capital Management
New York
$3.08M 402,197 -155,132 -28%
EAM
24
Exome Asset Management
New York
$2.09M 273,413 +273,413 New
Wellington Management Group
25
Wellington Management Group
Massachusetts
$1.87M 244,200 +244,200 New
1
2 3 4